<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">850</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Review of the article “Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer”</article-title><trans-title-group xml:lang="ru"><trans-title>Рецензия на статью «Спасительная высокодозная брахитерапия при локальном рецидиве рака предстательной железы»</trans-title></trans-title-group></title-group><pub-date date-type="pub" iso-8601-date="2018-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2018</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>175</fpage><lpage>176</lpage><history><date date-type="received" iso-8601-date="2018-07-06"><day>06</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-07-06"><day>06</day><month>07</month><year>2018</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/850">https://oncourology.abvpress.ru/oncur/article/view/850</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1.	Grado G.L., Collins J.M., Kriegshauser J.S. et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999;53(1):2–10. PMID: 9886580.</mixed-citation><mixed-citation xml:lang="ru">Grado G.L., Collins J.M., Kriegshauser J.S. et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999;53(1):2–10. PMID: 9886580.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2.	Nguyen P.L., Chen M.H., D’Amico A.V. et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 2007;110(7):1485–92. PMID: 17701957. DOI: 10.1002/cncr.22934.</mixed-citation><mixed-citation xml:lang="ru">Nguyen P.L., Chen M.H., D’Amico A.V. et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 2007;110(7):1485–92. PMID: 17701957. DOI: 10.1002/cncr.22934.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3.	Peters M., Maenhout M., Van der Voort van Zyp J.R. et al. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 2014;112(1):77–82. PMID: 24998704. DOI: 10.1016/j.radonc.2014.06.013.</mixed-citation><mixed-citation xml:lang="ru">Peters M., Maenhout M., Van der Voort van Zyp J.R. et al. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 2014;112(1):77–82. PMID: 24998704. DOI: 10.1016/j.radonc.2014.06.013.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4.	Yamada Y., Kollmeier M.A., Pei X. et al. A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 2014;13(2):111–6. PMID: 24373762. DOI: 10.1016/j.brachy.2013.11.005.</mixed-citation><mixed-citation xml:lang="ru">Yamada Y., Kollmeier M.A., Pei X. et al. A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 2014;13(2):111–6. PMID: 24373762. DOI: 10.1016/j.brachy.2013.11.005.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5.	Солодкий В.А., Павлов А.Ю., Цыбульский А.Д. Спасительная брахитерапия высокой мощности дозы при местном рецидиве рака предстательной железы после радикальных радиотерапевтических методов лечения. Онкоурология 2016;12(4):81–6.</mixed-citation><mixed-citation xml:lang="ru">Солодкий В.А., Павлов А.Ю., Цыбульский А.Д. Спасительная брахитерапия высокой мощности дозы при местном рецидиве рака предстательной железы после радикальных радиотерапевтических методов лечения. Онкоурология 2016;12(4):81–6.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6.	Kaljouw E., Pieters B.R., Kovács G., Hoskin P.J. A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study. Radiother Oncol 2016;118(1):122–30. PMID: 26549865. DOI: 10.1016/j.radonc.2015.10.021.</mixed-citation><mixed-citation xml:lang="ru">Kaljouw E., Pieters B.R., Kovács G., Hoskin P.J. A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study. Radiother Oncol 2016;118(1):122–30. PMID: 26549865. DOI: 10.1016/j.radonc.2015.10.021.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
